Drug or device? Canada demystifies classification
15 March 2013
- Predicting the future of EU genetic testing regulation - opportunities and pitfalls
- France: a more challenging market with the winds of change
- Report calls for more US FDA scrutiny on increase in device submission withdrawals
- EU regs for drug-device combinations get more complicated – time for a rewrite?
Other Informa News